Terconazole - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for terconazole and what is the scope of freedom to operate?

Terconazole is the generic ingredient in three branded drugs marketed by Janssen Pharms, Fougera Pharms, Fougera Pharms Inc, Taro, and Padagis Israel, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for terconazole. Eight suppliers are listed for this compound.

Summary for terconazole

US Patents:	0
Tradenames:	3
Applicants:	5
NDAs:	10
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	59
Clinical Trials:	8
Patent Applications:	5,623
Drug Prices:	Drug price trends for terconazole
What excipients (inactive ingredients) are in terconazole?	terconazole excipients list
DailyMed Link:	terconazole at DailyMed

See drug prices for terconazole

Recent Clinical Trials for terconazole

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hatem AbuHashim	N/A
Assiut University	Phase 3
Curatek Pharmaceuticals, LLC	Phase 3

See all terconazole clinical trials

Pharmacology for terconazole

Drug Class	Azole Antifungal

Anatomical Therapeutic Chemical (ATC) Classes for terconazole

G01AG	Triazole derivatives
G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for terconazole

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Israel	TERCONAZOLE	terconazole	SUPPOSITORY;VAGINAL	077149-001	Mar 17, 2006	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fougera Pharms	TERCONAZOLE	terconazole	SUPPOSITORY;VAGINAL	076850-001	Jul 12, 2006		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Janssen Pharms	TERAZOL 7	terconazole	CREAM;VAGINAL	019579-001	Dec 31, 1987		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for terconazole

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	TERAZOL 3	terconazole	CREAM;VAGINAL	019964-001	Feb 21, 1991	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	TERAZOL 3	terconazole	SUPPOSITORY;VAGINAL	019641-001	May 24, 1988	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	TERAZOL 7	terconazole	CREAM;VAGINAL	019579-001	Dec 31, 1987	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.